Healing & Recovery · researchUpdated Nov 2026

KLOW Peptide Blend (80mg) Dosage & Reconstitution Protocol

GHK-Cu + BPC-157 + TB-500 + KPV Blend

An 80 mg four-peptide vial that takes the GLOW formula (50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500) and adds 10 mg KPV, the anti-inflammatory alpha-MSH tripeptide. KLOW is positioned for users who want skin and tissue remodeling plus targeted inflammation control for gut, skin, or autoimmune-type flare-ups.

Typical Dose
2–4 mg
Frequency
Daily
Cycle Length
4–8 weeks
Administration
subcutaneous
KLOW Peptide Blend (80mg) lyophilized reference vialKLOW Peptide Blend (80mg) Reference Vial
Lyophilized Powder · U-100 Syringe ReferenceCalculate Draw ↓

Multi-Peptide Vial Composition

KLOW Peptide Blend (80mg) Active Blend Ratio

KLOW Peptide Blend (80mg) Quick Reference

Select your vial strength to update all reference concentrations, dosage tables, and syringe draws on this page.

Vial strength:
KLOW Peptide Blend (80mg) Quick Reference (80 mg Vial)100 units = 1.0 mL · 1 unit = 0.01 mL
Vial contents
80 mg KLOW Peptide Blend (80mg)
Final volume (Bacteriostatic Water)
2 mL (200 units)
Concentration
40 mg/mL
One U-100 syringe unit
400 mcg in 0.01 mL

Arithmetic summary: Reconstituting a 80 mg KLOW Peptide Blend (80mg) vial with 2 mL of bacteriostatic water yields 40 mg/mL. Every 10 units (0.10 mL) on a U-100 insulin syringe delivers 4000 mcg.

KLOW Peptide Blend (80mg) 80 mg lyophilized reference vialKLOW Peptide Blend (80mg) · 80 mg Vial

How Much To Draw

Select a row to preview the draw on the syringe. Values are reference figures from the literature, not medical advice.

80 mg Vial · 2 mL BAC Water · 400 mcg Per Unit
PhaseDosemLUnitsDoses
BeginnerOnce daily · Weeks 1–22 mg (1.25 mg GHK-Cu / 250 BPC / 250 TB / 250 KPV)0.05540
StandardOnce daily · Weeks 3–44 mg (2.5 mg GHK-Cu / 500 BPC / 500 TB / 500 KPV)0.101020
TargetOnce daily · Weeks 5–8+6 mg (3.75 mg GHK-Cu / 750 BPC / 750 TB / 750 KPV)0.151513
  • The 5:1:1:1 ratio is fixed by the vial; each 4 mg dose delivers 2.5 mg GHK-Cu and 0.5 mg each of BPC-157, TB-500 and KPV.
  • Reconstituted vials are generally used within 28–30 days refrigerated, so supply plans allow at least one vial per 4 weeks even when a vial holds more doses.

Interactive U-100 Syringe Scale

U-100 syringe drawn to 5 units (0.05 mL), 2 mg (1.25 mg GHK-Cu / 250 BPC / 250 TB / 250 KPV).

Click any dosing tier row above to preview that exact draw on the U-100 syringe scale.

How To Reconstitute KLOW Peptide Blend (80mg)

Four steps, in order. Work on a clean surface with washed hands and swab every vial top with alcohol first.

Get Lab-Tested Vials & BAC Water at ASCND Bio →
  1. Step 1: Drawing bacteriostatic water into a sterile U-100 syringeStep 01

    Draw Bacteriostatic Water

    Draw 2 mL of bacteriostatic water (0.9% benzyl alcohol) into a sterile syringe. Use bacteriostatic, not plain sterile water, so the multi-dose vial stays preserved between draws.

  2. Step 2: Injecting bacteriostatic water slowly down the inside glass wall of the peptide vialStep 02

    Equalize & Trickle Down The Glass Wall

    Pierce the stopper and angle the needle at 45° so the water runs slowly down the inside glass wall. Never spray directly onto the lyophilized puck: the jet foams the solution and can denature fragile peptide chains.

  3. Step 3: Gently rolling the peptide vial between fingertips until completely dissolvedStep 03

    Gently Roll, Never Shake

    Roll the vial gently between your fingers or swirl in a slow circle until the liquid is 100% clear with no undissolved particles. Shaking shears peptide bonds and traps air bubbles; if it clouds, let it rest in the fridge for 15 minutes.

  4. Step 4: Storing reconstituted peptide vials upright at 2 to 8 degrees CelsiusStep 04

    Label & Store At 2–8 °C (36–46 °F)

    Write the reconstitution date and concentration on the vial. Refrigerate upright at 2–8 °C (36–46 °F), protected from light, and use within 28–30 days. Do not freeze the reconstituted liquid.

Reconstitution & Dosage CalculatorU-100 Scale (100 units = 1.0 mL · 1 unit = 0.01 mL)

KLOW Peptide Blend (80mg) Reconstitution & Dosage Calculator

Convert a lyophilized peptide vial amount and bacteriostatic water volume into a reconstitution concentration, then translate your protocol dose and schedule into exact U-100 syringe units and multi-week vial supplies.

1Enter Vial & Water: Enter the peptide amount in your vial (mg) and bacteriostatic water volume (mL), or click Recommend Water.
2Enter Dose & Schedule: Enter your target dose in mcg or mg, pick your dosing schedule, and choose your U-100 syringe barrel.
3Follow Draw & Mixing Plan: Read the exact U-100 unit mark on the syringe, 4-step reconstitution instructions, and vials required.
1

Reconstitution

Enter the peptide amount in the vial and the volume of bacteriostatic or sterile water you plan to add.

mg
mL

Concentration

How much peptide each mL of solution contains after mixing.

5 mg/mL

Per 1 unit (0.01 mL)50 mcg
Per 10 units (0.1 mL)500 mcg
2

Your Dose & Schedule

Enter the dose from your protocol, select your dosing schedule, and pick the insulin syringe you are using.

1 mg = 1,000 mcg
Insulin syringe (U-100)

100-unit (1 mL): marks every 2 units. Standard barrel for draws up to 100 units.

Your Draw & Reconstitution Plan

✓ Aligns cleanly on graduation mark

Draw to

5units

Pull plunger seal to line 5

Volume

0.05 mL

Delivers 250 mcg

Doses per vial

20

Lasts 20 days (Once daily)

4-Week Schedule Supply

2 vials

28 doses · 2.0 mL BAC water

To-Scale U-100 Insulin Syringe (100-Unit / 1.0 mL Barrel)Read volume at the leading edge of the black plunger seal facing the needle
10 units

How to Reconstitute for Your Dosage Schedule

Once Daily
  1. 1Equilibrate & Sanitize: Remove your 5 mg vial from freezer storage and allow it to equilibrate at room temperature for 15–20 minutes. Swab both stoppers with 70% isopropyl alcohol.
  2. 2Draw & Inject Diluent Down Wall: Draw 1.0 mL (100 units) of bacteriostatic water and inject slowly down the inside glass wall at a 45° angle to prevent foaming.
  3. 3Swirl Gently & Refrigerate: Gently swirl or roll until dissolved (do not shake). Your concentration is 5 mg/mL (50 mcg/unit). Label and refrigerate at 2–8 °C.
  4. 4Draw Your Scheduled Dose: For each 250 mcg injection, pull the plunger to 5 units (0.05 mL) on your U-100 syringe.

Supplies Needed by Schedule Duration

5 mg vial · 250 mcg/dose
DurationTotal PeptideVials RequiredU-100 SyringesBAC Water

For educational and research calculations only. Always confirm calculations independently before use.

Supplies Needed for KLOW Peptide Blend (80mg)

Plan vials, U-100 insulin syringes, bacteriostatic water, and sterile alcohol prep pads by protocol duration.

Bacteriostatic water, lyophilized peptide vial, U-100 insulin syringes, and sterile alcohol prep pads
4 Core Supplies: 80 mg KLOW Peptide Blend (80mg) vials, Bacteriostatic Water (0.9% benzyl alcohol), U-100 insulin syringes, and 70% isopropyl alcohol pads.

1-, 2-, and 4-Week Supply Reference (80 mg Vial Format)

4 mg (2.5 mg GHK-Cu / 500 BPC / 500 TB / 500 KPV) · Once daily

KLOW Peptide Blend (80mg) Vials (80 mg each):

  • 1 week (28 mg total):1 vial required
  • 2 weeks (56 mg total):1 vial required
  • 4 weeks (112 mg total):2 vials required

U-100 Insulin Syringes & Alcohol Pads:

  • 1 week:7 syringes · 14 pads
  • 2 weeks:14 syringes · 28 pads
  • 4 weeks:28 syringes · 56 pads

8 Weeks

80 mg Vial
VialsKLOW Peptide Blend (80mg) mg vials
5
U-100 Syringesone sterile syringe per dose
61
BAC Water30 mL multi-dose vials
1
Alcohol Padsvial stopper + skin prep
117

56 total doses over 8 weeks

12 Weeks

80 mg Vial
VialsKLOW Peptide Blend (80mg) mg vials
7
U-100 Syringesone sterile syringe per dose
91
BAC Water30 mL multi-dose vials
2
Alcohol Padsvial stopper + skin prep
175

84 total doses over 12 weeks

16 Weeks

80 mg Vial
VialsKLOW Peptide Blend (80mg) mg vials
9
U-100 Syringesone sterile syringe per dose
121
BAC Water30 mL multi-dose vials
2
Alcohol Padsvial stopper + skin prep
233

112 total doses over 16 weeks

Synergistic Protocols

Popular KLOW Peptide Blend (80mg) Stacks & Co-Administration

Common research and clinical combinations pairing KLOW Peptide Blend (80mg) with complementary pathways.

Gold-Standard Tissue & Tendon RepairCycle: 6–12 weeks on · 2–4 weeks off

The Wolverine Stack (BPC-157 + TB-500)

Accelerates tendon, ligament, muscle, and joint recovery by pairing localized angiogenesis (BPC-157) with systemic actin upregulation (TB-500).

CompoundProtocol DoseTiming & Route
BPC-157250–500 mcg daily (10–20 U on 5mg/2mL)Once or split AM/PM SubQ
TB-500 (Thymosin Beta-4)2.0–2.5 mg twice weekly (or 350–500 mcg daily)SubQ abdominal or near injury

Stacking Note: Can be drawn into the same insulin syringe immediately prior to injection or purchased as a pre-mixed 10mg/10mg blend vial.

70 mg 3-Compound Collagen & Regeneration BlendCycle: 6–8 weeks on · 4 weeks off

The GLOW Protocol (GHK-Cu + BPC-157 + TB-500)

Combines high-dose copper peptide (50 mg GHK-Cu) with 10 mg BPC-157 and 10 mg TB-500 to remodel collagen, elastin, skin density, and connective tissue while minimizing copper injection sting.

CompoundProtocol DoseTiming & Route
GHK-Cu (Copper Peptide)1.75–2.5 mg per daily drawOnce daily SubQ (3 mL BAC in 70 mg vial)
BPC-157350–500 mcg per daily drawCo-administered in blend
TB-500350–500 mcg per daily drawCo-administered in blend

Stacking Note: Standard 70 mg GLOW vial reconstituted with 3.0 mL BAC water: drawing 7–10 units delivers ~1.6–2.3 mg GHK-Cu + 330–460 mcg each of BPC-157 and TB-500.

80 mg 4-Compound Anti-Inflammatory & Gut/Skin StackCycle: 8 weeks on · 4 weeks off

The KLOW Protocol (GHK-Cu + BPC-157 + TB-500 + KPV)

Adds 10 mg KPV (alpha-MSH tripeptide) to the GLOW formula to downregulate NF-kB/TNF-alpha systemic and gastrointestinal inflammation.

CompoundProtocol DoseTiming & Route
GHK-Cu + BPC-157 + TB-50050 mg / 10 mg / 10 mg baseOnce daily SubQ (3 mL BAC in 80 mg vial)
KPV Tripeptide350–500 mcg per daily drawCo-administered in 80 mg KLOW vial

Stacking Note: Ideal for protocols targeting simultaneous gut mucosal repair, autoimmune calm, and dermal/tendon remodeling.

Subcutaneous Injection Sites & Storage

Rotate sites with every injection so no single area is used twice in a row. Swab with alcohol and let it dry for 10 seconds before injecting.

3D anatomical map showing abdomen (2 inches from navel), outer anterior thigh, and upper arm subcutaneous injection zones

Zone 01

Abdomen

≥ 2 in away from navel

Zone 02

Outer Thigh

Middle third, anterior-lateral

Zone 03

Upper Arm

Posterior / outer tricep pad

Pinch & Needle Angle

90° · 4–8 mm (31 G) short needle

Standard U-100 insulin syringe: pinch a light fold and insert straight in at 90°.

45° · 12.7 mm (1/2 in) needle

Longer needle or leaner area: pinch a 1-inch fold and enter at 45° into fat.

Aseptic Injection Checklist

• Use a brand-new sterile U-100 syringe for every draw (never reuse needles).

• Swab both the vial rubber stopper and injection site with 70% isopropyl alcohol and let dry.

• Rotate clockwise around the abdomen or alternate left/right thigh to prevent lipohypertrophy.

Lyophilized Powder (Unmixed)

Freezer −20 °C Long-Term · Fridge Short-Term

Unmixed freeze-dried vials stay stable for months in the refrigerator and 1–2+ years at −20 °C (0 °F) in the dark. Let the vial warm to room temperature before opening.

Reconstituted Liquid (Mixed)

Refrigerate 2–8 °C (36–46 °F) · Use Within 30 Days

Keep refrigerated and out of light once mixed with bacteriostatic water. Never freeze reconstituted liquid — ice crystals shear the dissolved peptide chains.

Pharmacology & Evidence

Mechanism & Clinical Research

How It Works

Builds on the GLOW stack: GHK-Cu drives collagen and matrix remodeling, BPC-157 and TB-500 supply angiogenic and cell-migration repair signals. KPV (Lys-Pro-Val) adds inhibition of NF-κB activation and reduced pro-inflammatory cytokine release (IL-6, TNF-α) in epithelial and immune cells, which is why the blend is often chosen for inflammatory skin and gut conditions.

Common Dosing References

subcutaneous

2-4mg · Daily

4-8 weeks

subcutaneous

4-6mg · 5x weekly

8-12 weeks

Research use only. Not medical advice.

What The Research Shows

  1. 2010

    KPV anti-inflammatory activity in colitis models

    KPV reduced intestinal inflammation and NF-κB activity in rodent colitis, including when delivered orally via nanoparticles

  2. 2018

    GHK-Cu and skin regeneration

    Copper peptide increased collagen synthesis and improved skin density and elasticity in human dermal studies

Regulatory Status

Research compound; not FDA-approved. None of the four components is approved for injectable human use.

Clinical Profile

Potential Benefits

  • Skin regeneration and collagen support
  • Reduced inflammatory skin flares (eczema, psoriasis-type redness)
  • Gut lining support and reduced intestinal inflammation
  • Wound, scar, and tendon recovery
  • Hair and nail quality
  • Systemic inflammation control

Reported Side Effects

  • Injection site stinging and burning (GHK-Cu component)
  • Redness, welts, or bruising at the site
  • Transient fatigue
  • Headache
  • Mild nausea

Provider Directory

Confirmed Clinics & Sourcing

Sourcing Notes

Sold as an 80 mg lyophilized vial by a smaller set of research vendors than GLOW. Ask for a four-peptide COA; KPV is the component most often under-reported. Expect a blue-tinted cake from the copper peptide.

Free Guide

Get KLOW Peptide Blend (80mg) research updates

New studies, regulatory changes and sourcing notes on the peptides you follow. One email a week, no spam.

Free. No spam. Unsubscribe anytime. From GLP1Search.

Find peptide-aware clinics

Use location pages to compare clinics with peptide therapy signals and verify clinical oversight before treatment.

Search Local Clinics